Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol

Chemotherapy related toxicities have been the major factor limiting the success of acute lymphoblastic leukemia (ALL) induction therapy. Several factors, including the pharmacogenetics of asparaginase and anthracyclines, could contribute to difference in treatment outcome in ALL. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Sara, Ameer, Sonia, Shabana, N. A., Ahmed, Mehboob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660848/
https://www.ncbi.nlm.nih.gov/pubmed/34887513
http://dx.doi.org/10.1038/s41598-021-03208-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660848/
https://www.ncbi.nlm.nih.gov/pubmed/34887513
http://dx.doi.org/10.1038/s41598-021-03208-9

Ejemplares similares